For instance, Hallaert et al. (2020) specifically demonstrated a survival benefit for partial resection in comparison to biopsy in MGMT-unmethylated IDH-wildtype GBM, supporting our pooled finding that subMR seems to be superior to biopsy. This evidence concerns the gene MGMT and glioblastoma.